{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:14:10Z","timestamp":1793121250460,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science and Technology Development Fund, Macau SAR","award":["(File no. 0032\/2018\/A1)"],"award-info":[{"award-number":["(File no. 0032\/2018\/A1)"]}]},{"name":"The Science and Technology Development Fund, Macau SAR","award":["File no. 0041\/2021\/ITP"],"award-info":[{"award-number":["File no. 0041\/2021\/ITP"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic kidney disease (CKD) is a global public health issue. The diagnosis of CKD would be considerably enhanced by discovering novel biomarkers used to determine the glomerular filtration rate (GFR). Small molecule metabolites related to kidney filtration function that might be utilized as biomarkers to measure GFR more accurately could be found via a metabolomics analysis of blood samples taken from individuals with varied glomerular filtration rates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An untargeted metabolomics study of 145 plasma samples was performed using ultrahigh-performance liquid chromatography tandem mass spectrometry (UPLC\u2013MS\/MS). The 145 samples were divided into four groups based on the patient\u2019s measured glomerular filtration rates (mGFRs) determined by the iohexol plasma clearance rate. The data were analyzed using random forest analyses and six other unique statistical analyses. Principal component analysis (PCA) was conducted using R software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A large number of metabolites involved in various metabolic pathways changed significantly between groups with different GFRs. These included metabolites involved in tryptophan or pyrimidine metabolism. The top 30 metabolites that best distinguished between the four groups in a random forest plot analysis included 13 amino acids, 9 nucleotides, and 3 carbohydrates. A panel of metabolites (including hydroxyaparagine, pseudouridine, C-glycosyltryptophan, erythronate, N-acetylalanine, and 7-methylguanidine) for estimating GFR was selected for future testing in targeted analyses by combining the candidate lists with the six other statistical analyses. Both hydroxyasparagine and N,N-dimethyl-proline-proline are unique biomarkers shown to be inversely associated with kidney function that have not been reported previously. In contrast, 1,5-anhydroglucitol (1,5-AG) decreases with impaired renal function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This global untargeted metabolomics study of plasma samples from patients with different degrees of renal function identified potential metabolite biomarkers related to kidney filtration. These novel potential metabolites provide more insight into the underlying pathophysiologic processes that may contribute to the progression of CKD, lead to improvements in the estimation of GFR and provide potential therapeutic targets to improve kidney function.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03147-9","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T15:11:34Z","timestamp":1682089894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Metabolomics study of metabolites associated with the glomerular filtration rate"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongquan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiwa Ao","family":"Ieong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tou","family":"Tou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsungyang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"issue":"9818","key":"3147_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet. 2012;379(9818):815\u201322.","journal-title":"The Lancet"},{"issue":"7","key":"3147_CR2","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034\u201347.","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"3147_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305.","journal-title":"N Engl J Med"},{"issue":"3","key":"3147_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0022-5347(17)37891-6","volume":"146","author":"SC Brown","year":"1991","unstructured":"Brown SC, O\u2019Reilly PH. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard. J Urol. 1991;146(3):675\u20139.","journal-title":"J Urol"},{"issue":"11","key":"3147_CR5","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1681\/ASN.2009020171","volume":"20","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009;20(11):2305\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"9811","key":"3147_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey AS, Coresh J. Chronic kidney disease. The Lancet. 2012;379(9811):165\u201380.","journal-title":"The Lancet"},{"issue":"1","key":"3147_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/kisup.2012.77","volume":"3","author":"G Eknoyan","year":"2013","unstructured":"Eknoyan G, Lameire N, Eckardt K, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3(1):5\u201314.","journal-title":"Kidney Int"},{"issue":"5","key":"3147_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","volume":"63","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis. 2014;63(5):820\u201334.","journal-title":"Am J Kidney Dis"},{"key":"3147_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12967-015-0674-y","volume":"13","author":"J Chen","year":"2015","unstructured":"Chen J, Tang H, Huang H, et al. Development and validation of new glomerular filtration rate predicting models for chinese patients with type 2 diabetes. J Translational Med. 2015;13:317.","journal-title":"J Translational Med"},{"issue":"1","key":"3147_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"3147_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41581-019-0191-y","volume":"16","author":"AS Levey","year":"2020","unstructured":"Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA. Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol. 2020;16(1):51\u201364.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3147_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.ackd.2017.10.004","volume":"25","author":"LA Inker","year":"2018","unstructured":"Inker LA, Levey AS, Coresh J. Estimated glomerular filtration rate from a panel of filtration markers-hope for increased accuracy beyond measured glomerular filtration rate? Adv Chronic Kidney Dis. 2018;25(1):67\u201375.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"3147_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/ndt\/gfy094","volume":"34","author":"J Coresh","year":"2019","unstructured":"Coresh J, Inker LA, Sang Y, et al. Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study. Nephrol Dialysis Transplantation. 2019;34(5):825\u201333.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"3","key":"3147_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2215\/CJN.05540512","volume":"8","author":"VO Shah","year":"2013","unstructured":"Shah VO, Townsend RR, Feldman HI, et al. Plasma metabolomic profiles in different stages of CKD. Clin J Am Soc Nephrol. 2013;8(3):363\u201370.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"3147_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000446484","volume":"43","author":"EP Rhee","year":"2016","unstructured":"Rhee EP, Clish CB, Wenger J, et al. Metabolomics of chronic kidney disease progression: a case\u2013control analysis in the chronic renal insufficiency cohort study. Am J Nephrol. 2016;43(5):366\u201374.","journal-title":"Am J Nephrol"},{"key":"3147_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jpba.2017.10.036","volume":"149","author":"S Benito","year":"2018","unstructured":"Benito S, S\u00e1nchez-Ortega A, Unceta N, et al. Plasma biomarker discovery for early chronic kidney disease diagnosis based on chemometric approaches using LC-QTOF targeted metabolomics data. J Pharm Biomed Anal. 2018;149:46\u201356.","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"3147_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","volume":"64","author":"I Soveri","year":"2014","unstructured":"Soveri I, Berg UB, Bj\u00f6rk J, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411\u201324.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3147_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ki.2009.398","volume":"77","author":"GJ Schwartz","year":"2010","unstructured":"Schwartz GJ, Abraham AG, Furth SL, Warady BA, Mu\u00f1oz A. Optimizing iohexol plasma disappearance curves to measure the glomerular filtration rate in children with chronic kidney disease. Kidney Int. 2010;77(1):65\u201371.","journal-title":"Kidney Int"},{"issue":"1","key":"3147_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12882-018-0965-7","volume":"19","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Sui Z, Yu Z, et al. Accuracy of iohexol plasma clearance for GFR-determination: a comparison between single and dual sampling. BMC Nephrol. 2018;19(1):174.","journal-title":"BMC Nephrol"},{"key":"3147_CR20","doi-asserted-by":"crossref","unstructured":"Peng H, Liu X, Ieong CA et al. Identification of Metabolite Markers Associated with Kidney Function.J Immunol Res. 2022 Jul 26;2022","DOI":"10.1155\/2022\/6190333"},{"issue":"5","key":"3147_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1049\/syb2.12031","volume":"15","author":"H Peng","year":"2021","unstructured":"Peng H, Zhu H, Ieong CWA, et al. A two-stage neural network prediction of chronic kidney disease. IET Syst Biol. 2021;15(5):163\u201371.","journal-title":"IET Syst Biol"},{"issue":"11","key":"3147_CR22","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, Keun HC, Ebbels TM, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2(11):2692\u2013703.","journal-title":"Nat Protoc"},{"key":"3147_CR23","doi-asserted-by":"crossref","unstructured":"Evans A, Bridgewater B, Liu Q et al. \u201cHigh resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics,\u201d Metabolomics, vol.\u00a04, pp.\u00a010000132, 2014.","DOI":"10.4172\/2153-0769.1000132"},{"issue":"7","key":"3147_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and toward mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"3147_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher B, Adamski J. Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol. 2017;13(5):269\u201384.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"3147_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.semnephrol.2018.01.009","volume":"38","author":"A K\u00f6ttgen","year":"2018","unstructured":"K\u00f6ttgen A, Raffler J, Sekula P, Kastenm\u00fcller G. Genome-wide association studies of metabolite concentrations (mGWAS): relevance for nephrology. Semin Nephrol. 2018;38(2):151\u201374.","journal-title":"Semin Nephrol"},{"issue":"4","key":"3147_CR27","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1681\/ASN.2014111099","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Goek ON, Quaye L, et al. A metabolome-wide association study of kidney function and disease in the general population. J Am Soc Nephrol. 2016;27(4):1175\u201388.","journal-title":"J Am Soc Nephrol"},{"issue":"43","key":"3147_CR28","doi-asserted-by":"publisher","first-page":"26630","DOI":"10.1016\/S0021-9258(18)47065-2","volume":"269","author":"RW Glanville","year":"1994","unstructured":"Glanville RW, Qian RQ, McClure DW, Maslen CL. Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein. J Biol Chem. 1994;269(43):26630\u20134.","journal-title":"J Biol Chem"},{"issue":"3","key":"3147_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.18388\/abp.2000_3996","volume":"47","author":"A Furmanek","year":"2000","unstructured":"Furmanek A, Hofsteenge J. Protein C-mannosylation: facts and questions. Acta Biochim Pol. 2000;47(3):781\u20139.","journal-title":"Acta Biochim Pol"},{"key":"3147_CR30","doi-asserted-by":"crossref","unstructured":"Manabe S, Marui Y, Ito Y. \u201cTotal synthesis of mannosyl tryptophan and its derivatives,\u201d Chemistry, vol.\u00a09, no. 6, pp.\u00a01435\u20131447, 2003.","DOI":"10.1002\/chem.200390163"},{"issue":"1","key":"3147_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/cclm-2012-0880","volume":"52","author":"P Gillery","year":"2014","unstructured":"Gillery P, Jaisson S. Post-translational modification derived products (PTMDPs): toxins in chronic diseases? Clin Chem Lab Med. 2014;52(1):33\u20138.","journal-title":"Clin Chem Lab Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03147-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03147-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03147-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T15:12:54Z","timestamp":1682089974000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03147-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3147"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03147-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"18 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Ethics Commission of Kiang Wu Hospital (KWH 2018\u2013001). All volunteers were informed and signed consent forms. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have stated that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}